z-logo
open-access-imgOpen Access
Update on the management of vascular patients with COVID-19
Author(s) -
Grigoris T. Gerotziafas,
M. Catalano
Publication year - 2020
Publication title -
journal of theoretical and applied vascular research
Language(s) - English
Resource type - Journals
ISSN - 2532-0831
DOI - 10.24019/jtavr.94
Subject(s) - angiology , medicine , vascular medicine , diabetes mellitus , cardiology , thrombosis , vascular disease , population , disease , intensive care medicine , environmental health , endocrinology
Attention has to be payed to patients with vascular disease (VD) cardiovascular risk factors (VD-CVR) and COVID-19. In fact, COVID-19 is also manifested with hypercoagulability, pulmonary intravascular coagulation, microangiopathy, and venous thromboembolism (VTE) or arterial thrombosis and VP are a frail population. Predisposing risk factors to severe COVID-19 are male sex, underlying cardiovascular disease, or cardiovascular risk factors including non-controlled diabetes mellitus or arterial hypertension, obesity, and advanced age. The VAS-European Independent Foundation in Angiology/Vascular Medicine has recently published an integral strategy for the management of patients with VD or cardiovascular risk factors (VD-CVR) and COVID-19. This paper represents a short summary.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here